35.25
Biolife Solutions Inc stock is traded at $35.25, with a volume of 344.31K.
It is down -0.79% in the last 24 hours and up +8.39% over the past month.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
See More
Previous Close:
$35.53
Open:
$35.07
24h Volume:
344.31K
Relative Volume:
0.32
Market Cap:
$1.72B
Revenue:
$96.21M
Net Income/Loss:
$-12.13M
P/E Ratio:
-112.62
EPS:
-0.313
Net Cash Flow:
$10.64M
1W Performance:
-3.11%
1M Performance:
+8.39%
6M Performance:
+70.54%
1Y Performance:
+36.26%
Biolife Solutions Inc Stock (BLFS) Company Profile
Name
Biolife Solutions Inc
Sector
Industry
Phone
(425) 401-1400
Address
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Compare BLFS vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
BLFS
Biolife Solutions Inc
|
35.25 | 1.81B | 96.21M | -12.13M | 10.64M | -0.313 |
|
ISRG
Intuitive Surgical Inc
|
366.70 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
184.74 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
70.50 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
RMD
Resmed Inc
|
228.35 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
|
MDLN
Medline Inc
|
36.59 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Biolife Solutions Inc Stock (BLFS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-22-25 | Resumed | Stephens | Overweight |
| Sep-30-24 | Initiated | H.C. Wainwright | Buy |
| Apr-04-24 | Initiated | Jefferies | Buy |
| Jul-11-23 | Initiated | Craig Hallum | Buy |
| Apr-25-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Oct-19-21 | Initiated | B. Riley Securities | Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| May-14-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-23-21 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-22-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-18-20 | Initiated | Cowen | Outperform |
| Aug-11-20 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-08-20 | Reiterated | Maxim Group | Buy |
| Feb-24-20 | Initiated | Lake Street | Buy |
| Feb-19-20 | Initiated | The Benchmark Company | Buy |
| Feb-06-20 | Resumed | B. Riley FBR | Buy |
| Jan-08-20 | Initiated | Stephens | Overweight |
| Nov-21-19 | Initiated | Oppenheimer | Outperform |
| Jul-22-19 | Initiated | H.C. Wainwright | Buy |
| Nov-10-17 | Reiterated | Maxim Group | Buy |
| Sep-19-17 | Reiterated | Maxim Group | Buy |
| Jul-05-17 | Upgrade | Janney | Neutral → Buy |
| Mar-10-17 | Reiterated | Maxim Group | Buy |
| Jan-19-17 | Initiated | Maxim Group | Buy |
View All
Biolife Solutions Inc Stock (BLFS) Latest News
Bank of America Corp DE Increases Stake in BioLife Solutions, Inc. $BLFS - MarketBeat
Summit Creek Advisors LLC Acquires New Position in BioLife Solutions, Inc. $BLFS - MarketBeat
BioLife Solutions Reports Fourth Quarter and Full Year 2025 Fina - GuruFocus
Diamond Hill Capital Management LLC Investment Advisor Acquires New Stake in BioLife Solutions, Inc. $BLFS - MarketBeat
Short Interest in BioLife Solutions, Inc. (NASDAQ:BLFS) Rises By 59.1% - MarketBeat
BLFS Q2 2026 Earnings: EPS Beats Consensus by 17.65% as Shares Gain 1.08%Earnings Call Q&A - vinanet.vn
BioLife Solutions (NASDAQ:BLFS) Reaches New 12-Month HighShould You Buy? - MarketBeat
Biolife Solutions stock hits 52-week high at 35.36 USD By Investing.com - Investing.com South Africa
Biolife Solutions stock hits 52-week high at 35.36 USD - Investing.com
BioLife’s Sharp Swing To Profit Might Change The Case For Investing In BioLife Solutions (BLFS) - simplywall.st
Roubaix Capital, LLC's BioLife Solutions Inc(BLFS) Holding History - GuruFocus
BioLife Solutions, Inc. (NASDAQ:BLFS) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
BioLife Solutions, Inc. (BLFS) Stock Forecasts - Yahoo! Finance Canada
BioLife Solutions, Inc. (BLFS) Stock Analysis: Navigating a High Forward P/E Amid Robust Growth in the Healthcare Sector - DirectorsTalk Interviews
BioLife Solutions (NASDAQ:BLFS) Hits New 12-Month HighTime to Buy? - MarketBeat
BioLife Solutions Cut to Hold From Buy by Benchmark - Moomoo
Why BioLife Solutions (BLFS) Is Up 7.8% After Swinging To Q2 Profitability And What's Next - simplywall.st
Benchmark Co. Downgrades BioLife Solutions(BLFS.US) to Hold Rating - Moomoo
BioLife Solutions (BLFS) Stock Price Ignores A Sharp Turn To Profit - simplywall.st
BioLife Solutions Inc (BLFS) Stock News Today - TradingKey
BioLife Solutions Inc (BLFS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Royal Bank of Canada Purchases 66,010 Shares of BioLife Solutions, Inc. $BLFS - MarketBeat
BLFS Looks 16.4% Overvalued on GF Value™ Amid Strong Q2 Revenue Beat - GuruFocus
BioLife Solutions (BLFS) Is Up 7.2% After Swinging From Loss To Q2 ProfitWhat's Changed - Yahoo Finance
Is BioLife Solutions Inc (BLFS) Overvalued After Q2 Earnings Bea - GuruFocus
BLFS SWOT Analysis: Strong Revenue Growth Amidst Strategic Changes Revealed in 10-Q Filing - GuruFocus
BioLife Solutions (NASDAQ:BLFS) Posts Earnings Results, Beats Estimates By $0.88 EPS - MarketBeat
BLFS Technical Analysis & Stock Price Forecast - Intellectia AI
BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
BioLife Solutions, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
BioLife Solutions 2026: Revenue $28.47M, EPS $0.91— 10-Q Summary - TradingView
Earnings Flash (BLFS) BioLife Solutions, Inc. Reports Q2 Revenue $28.5M, vs. FactSet Est of $27.8M - marketscreener.com
BIOLIFE SOLUTIONS ($BLFS) Releases Q2 2026 Earnings - Quiver Quantitative
BioLife Solutions (NASDAQ: BLFS) plans cash-stock merger with Repligen - Stock Titan
BioLife Solutions reports Q2 2026 revenue $28.5M, GAAP net income $45.1M, adjusted EBITDA $7.4M - TradingView
BioLife Solutions, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BLFS: Q2 2026 revenue up 21% year-over-year; $1.5B acquisition by Repligen set for Q4 2026 - TradingView
BioLife Solutions (NASDAQ:BLFS) Hits New 52-Week HighStill a Buy? - MarketBeat
BioLife Solutions set to report earnings under takeover cloud By Investing.com - Investing.com Nigeria
Biolife Solutions stock hits 52-week high at 33.18 USD - Investing.com
Biolife Solutions stock hits 52-week high at 33.18 USD By Investing.com - Investing.com South Africa
BioLife Solutions set to report earnings under takeover cloud - Investing.com
Repligen Corporation (BLFS) sets cash and stock terms for BioLife Solutions buyout - stocktitan.net
BioLife Solutions, Inc. (BLFS) Stock Analysis: Navigating Growth with Precision in the Healthcare Sector - DirectorsTalk Interviews
Repligen to acquire BioLife Solutions in two-step merger; employee video details timeline - TradingView
BLFS Q1 2026 Earnings: Marginal EPS Miss Highlights Narrow Beat-and-Miss GapEarnings Miss Streak - Vinanet
BioLife Solutions, Inc. Revenue Breakdown – NASDAQ:BLFS - TradingView
BLFS Q1 2026 Earnings: EPS of $0.02 Slightly Misses Consensus EstimatesShort-Term Outlook - Vinanet
BLFS Q2'26 Earnings: revenue estimate is 27.80M USD - TradingView
Avoiding Lag: Real-Time Signals in (BLFS) Movement - Stock Traders Daily
Biolife Solutions stock hits 52-week high at 32.24 USD By Investing.com - Investing.com South Africa
Biolife Solutions Inc Stock (BLFS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Biolife Solutions Inc Stock (BLFS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Casdin Partners Master Fund, L | 10% Owner |
May 19 '26 |
Sale |
22.65 |
300,000 |
6,795,000 |
5,657,165 |
| Casdin Partners Master Fund, L | 10% Owner |
May 20 '26 |
Sale |
23.70 |
250,000 |
5,925,000 |
5,407,165 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):